Advanced search
Publication Cover
Acta Cardiologica Volume 62, 2007 - Issue 1
Submit an article Journal homepage
4
Views
0
CrossRef citations to date
0
Altmetric
Articles

Prognostic value of heart rate turbulence and heart rate variability in children with dilated cardiomyopathy

Cem≥it KarakurtDepartment of Pediatric Cardiology, Dr. Sami Ulus Children’s Hospital, Ankara, Turkey.Correspondence[email protected]
,
Kudret AytemirDepartment of Cardiology, University of Hacettepe, Ankara, Turkey.
,
Selmin KarademirDepartment of Pediatric Cardiology, Dr. Sami Ulus Children’s Hospital, Ankara, Turkey.
,
Metin SungurDepartment of Pediatric Cardiology, Dr. Sami Ulus Children’s Hospital, Ankara, Turkey.
,
Deniz OguzDepartment of Pediatric Cardiology, Dr. Sami Ulus Children’s Hospital, Ankara, Turkey.
,
Burhan ÖcalDepartment of Pediatric Cardiology, Dr. Sami Ulus Children’s Hospital, Ankara, Turkey.
&
Filiz ≤enocakDepartment of Pediatric Cardiology, Dr. Sami Ulus Children’s Hospital, Ankara, Turkey.
 show all
Pages 31-37 | Received 19 Jun 2006, Accepted 14 Oct 2006, Published online: 23 May 2017

References

  • Arola A, Tuominen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy: Prognostic indicators and outcome. Pediatrics 1998; 101(3): 369–76.
  • Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL. The natural history of idiopathic dilated car-diomyopathy. Am J Cardiol 1981; 47: 525–31.
  • Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331: 1564–75.
  • Grimm W, Glaveris C, Hofmann J, Menz V, Muller HH, Hufnagel G, Maisch B. Arrhythmia risk stratification in idio-pathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour Holler electro-cardiography. Am Heart J 2000; 140: 43–51.
  • Hartikainen JEK, Malik M, Staunton A, Poloniecki J, Camm AJ. Distinction between arrhythmic and nonar-rhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ven-tricular arrhythmias and left ventricular ejection fraction. J Am Coll Cardiol 1996; 28: 296–304.
  • Davies LC, Francis DP, Ponikowski P. Piepoli MF, Coats AJ. Relation of heart rate and blood pressure turbulence following ventricular complexes to baroreflex sensitivity in chronic congestive heart failure. Am J Cardiol 2001; 87: 737–42.
  • Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rol-nitzky L, Camm AJ, Bigger JT Jr, Schomig A. Heart rate tur-bulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 1999; 353(9162): 1390–6.
  • Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. For the American Society of Echocardiography Committee on Quantitation of Two-dimensional echocar-diography. J Am Soc Echocardiography 1989; 2: 358–67.
  • American Heart Association Inc. Task Force of the Euro-pean Society of Cardiology the North American Society of Pacing and Electrophysiology. Heart Rate Variability. Standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93: 1043–65.
  • Kasper EK, Agema WR, Hutchins GM, Deckers JW, Hare JM, Baughman KL. The causes of dilated cardiomyopathy in children. Circulation 1996: 94; 2021–38.
  • Park MK. Primary myocardial diseases. Park MK, Troxler RG (eds). Pediatric Cardiology for Practitioners, Mosby Inc., St. Louis, Missouri. 4th edition, 2002, pp 273-5.
  • Becker R, Heass M, Ick D, Krueger C, Bauer A, Senges-Becker JC, Voss F, Hilbel T, Niroomand F, Katus HA, Schoels W Role of nonsustained ventricular tachycardia and programmed ventricular stimulation for risk stratification in patients with idiopathic dilated cardiomyopathy. Basic Res Cardiol 2003; 98: 259–66.
  • Venugopalan P, Agarwal AK. Plasma catecholamine levels parallel severity of heart failure and have prognostic value in children with dilated cardiomyopathy. Eur J Heart Fail 2003; 5: 655–8.
  • La Rovere MT, Bigger JT, Marcus Fl, Mortara A, Schwartz PJ for the ATRAMI Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortal-ity after myocardial infarction. Lancet 1998; 351: 478–84.
  • Binder T, Frey B, Porenta G, Heinz G, Wutte M, Kreiner G, Gossinger H, Schmidinger H, Pacher R, Weber H. Prog-nostic value of heart rate variability in patients awaiting cardiac transplantation. Pacing Clin Electrophysiol 1992; 15: 2215–20.
  • Nolan J, Fox KAA, Fauchier L, Babuty D, Cosnay P, Fauchier JP. Heart rate variability and cardiac failure. Heart 1999; 81(5): 561–2.
  • Lombardi F, Mortara A. Heart rate variability and cardiac failure. Heart 1998; 80: 213–4.
  • Hartikainen JE, Malik M, Staunton A, Poloniecki J, Camm AJ. Distinction between arrhythmic and nonarrhythmic death after acute myocardial infarction based on heart rate variability, signal-averaged electrocardiogram, ventricular arrhythmias and left ventricular ejection fraction. J Am Coll Cardiol 1996; 28(2): 296–304.
  • Batchvarov VN, Hnatkova K, Poloniecki J, Camm AJ, Malik M. Prognostic value of heterogeneity of ventricular repo-larization in survivors of acute myocardial infarction. Clin Cardiol 2004; 27(11): 653–9.
  • De Martino G, Dello Russo A, Sanna T, et al. Prognostic role of heart rate turbulence in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2001; 22 (Suppl): 436, P2314.
  • Schneider R, Barthel P, Schmidt G. Methods for the assess-ment of heart rate turbulence in Holler ECGs. J Am Coll Cardiol 1999; 33 (Suppl A): 351A (abstract).
  • Malik M, Wichterle D, Schmidt G. Heart-rate turbulence. G Ital Cardiol 1999; 29 (Suppl 5): 65–9.
  • Mrowka R, Persson PB, Theres H, Patzak A. Blunted arte-rial baroreflex causes pathological heart rate turbulence. Am J Physiol Regulatory Integrative Comp Physiol 2000; 279: 1171–5.
  • Bauer A, Kantelhardt JW, Barthel P, Schneider R, Makikallio T, Ulm K, Hnatkova K, Schomig A, Huikuri H, Bunde A, Malik M, Schmidt G. Deceleration capacity of heart rate as a predictor of mortality after myocardial infarc-tion: cohort study. Lancet 2006; 20: 367: 1674–81.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.